©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 675-687
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.675
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.675
Table 3 Classification of sclerosing encapsulating peritonitis according to underlying cause
| Primary (idiopathic) sclerosing encapsulating peritonitis |
| I Adolescent form |
| II Adult form |
| Secondary sclerosing encapsulating peritonitis |
| I Systemically induced by |
| Beta adrenergic blocking agents |
| Practolol |
| Timolol |
| Propanolol |
| Other drugs |
| Methotrexate |
| Protein S deficiency |
| Exposure to asbestosis |
| II Induced by possible local and/or systemic irritants |
| Peritoneal dialysis |
| Abdominal trauma |
| Abdominal surgery |
| Liver transplantation |
| Peritoneovenous shunt |
| Ventriculoperitoneal shunt |
| Peritoneal sarcoidosis |
| Liver cirrhosis |
| Peritoneal tuberculosis |
| Sarcoidosis |
| Familial mediterranean fever |
| Systemic lupus erythematosus |
| Gastrointestinal malignancy |
| Intraperitoneal chemotherapy |
| Fibrogenic foreign body |
| Endometriosis |
| Dermoid cyst rupture |
| Luteinized ovarian thecomas |
| Cytomegalovirus peritonitis |
| Recurrent peritonitis |
| Granulomatous peritonitis related with parasitic infestation |
- Citation: Akbulut S. Accurate definition and management of idiopathic sclerosing encapsulating peritonitis. World J Gastroenterol 2015; 21(2): 675-687
- URL: https://www.wjgnet.com/1007-9327/full/v21/i2/675.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.675